Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.

Literature DB >> 978396

Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.

V F Smolen.

Abstract

Mesh：

Substances：

Year: 1976 PMID： 978396 DOI： 10.1007/BF01063123

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

13 in total

1. Optimally predictive in vitro drug dissolution testing for in vivo bioavailability.

Authors: V F Smolen; W A Weigand
Journal: J Pharm Sci Date: 1976-12 Impact factor: 3.534

2. KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors: J G WAGNER; E NELSON
Journal: J Pharm Sci Date: 1964-11 Impact factor: 3.534

3. Application of analogue computer to measurement of intestinal absorption rates with tracers.

Authors: M SILVERMAN; A S BURGEN
Journal: J Appl Physiol Date: 1961-09 Impact factor: 3.531

4. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input in equilibrium to response relationships.

Authors: V F Smolen
Journal: J Pharmacokinet Biopharm Date: 1976-08

5. Drug input optimization: bioavailability-effected time-optimal control of multiple, simultaneous, pharmacological effects and their interrelationships.

Authors: V F Smolen; B D Turrie; W A Weigand
Journal: J Pharm Sci Date: 1972-12 Impact factor: 3.534

6. Determination of time course of in vivo pharmacological effects from in vitro drug-release testing.

Authors: V F Smolen
Journal: J Pharm Sci Date: 1971-06 Impact factor: 3.534

7. Drug-absorption analysis from pharmacological data. I. Method and confirmation exemplified for the mydriatic drug tropicamide.

Authors: V F Smolen; R D Schoenwald
Journal: J Pharm Sci Date: 1971-01 Impact factor: 3.534

8. Quantitative determination of drug bioavailability and biokinetic behavior from pharmacological data for ophthalmic and oral administrations of a mydriatic drug.

Authors: V F Smolen
Journal: J Pharm Sci Date: 1971-03 Impact factor: 3.534

9. Studies on absorption and excretion of drug. VII. A new estimation method for the release of drugs from dosage forms and the availability in vivo.

Authors: M Hanano
Journal: Chem Pharm Bull (Tokyo) Date: 1967-07 Impact factor: 1.645

10. Bioavailability analysis of chlorpromazine in humans from pupilometric data.

Authors: V F Smolen; H R Murdock; E J Williams
Journal: J Pharmacol Exp Ther Date: 1975-12 Impact factor: 4.030

14 in total

1. Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.

Authors: W Krzyzanski; W J Jusko
Journal: J Pharmacokinet Pharmacodyn Date: 2001-02 Impact factor: 2.745

2. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input in equilibrium to response relationships.

Authors: V F Smolen
Journal: J Pharmacokinet Biopharm Date: 1976-08

3. Relation between morphine pharmacokinetics and analgesia.

Authors: B E Dahlström; L K Paalzow; G Segre; A J Agren
Journal: J Pharmacokinet Biopharm Date: 1978-02

4. Bioavailability assessment from pharmacologic data: method and clinical evaluation.

Authors: G Stagni; A M Shepherd; Y Liu; W R Gillespie
Journal: J Pharmacokinet Biopharm Date: 1997-06

5. Bioavailability assessment and pharmacologic response: impact of first-pass loss when both drug and metabolites are active.

Authors: M Rowland
Journal: J Pharmacokinet Biopharm Date: 1988-12

6. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors: P Veng-Pedersen; W R Gillespie
Journal: J Pharmacokinet Biopharm Date: 1987-06

7. Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors: P Veng-Pedersen
Journal: J Pharmacokinet Biopharm Date: 1988-08